"Avoid approval issues with the FDA by turning to us for drug research. Our medical researchers in Dallas, TX, also conduct dermatology trials."

During the past decade, Modern Research Associates conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 26 clinical trials were completed, i.e. on average, 83.9% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 15 clinical trials were completed. i.e. 115.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Modern Research Associates" #1 sponsor was "Eli Lilly and Company" with 10 trials, followed by "Amgen" with 7 trials sponsored, "Janssen Research & Development, LLC" with 7 trials sponsored, "Pfizer" with 3 trials sponsored and "Journey Medical Corporation" with 3 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 18 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Modern Research Associates" #1 collaborator was "Incyte Corporation" with 3 trials as a collaborator, "AbbVie" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator, "Basilea Pharmaceutica" with 1 trials as a collaborator and "Dermira, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Modern Research Associates" are "Psoriasis" (14 trials), "Atopic Dermatitis" (8 trials), "Plaque Psoriasis" (7 trials), "Alopecia Areata" (2 trials) and "Hyperhidrosis" (2 trials). Many other conditions were trialed in "Modern Research Associates" in a lesser frequency.

Most popular intervention types in "Modern Research Associates" are "Drug" (40 trials), "Other" (6 trials) and "Biological" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (25 trials), "Apremilast" (3 trials), "Baricitinib" (3 trials), "Guselkumab" (3 trials) and "Ixekizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Modern Research Associates" are 42 trials for "All" genders.

Currently, there are NaN active trials in "Modern Research Associates". undefined are not yet recruiting, 3 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Modern Research Associates, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Modern Research Associates, 0 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".